Invention Grant
- Patent Title: Recombinant microorganisms exhibiting increased flux through a fermentation pathway
-
Application No.: US14961146Application Date: 2015-12-07
-
Publication No.: US10590406B2Publication Date: 2020-03-17
- Inventor: Michael Koepke , Alexander Paul Mueller , Loan Phuong Tran
- Applicant: LanzaTech New Zealand Limited
- Applicant Address: US IL Skokie
- Assignee: LANZATECH NEW ZEALAND LIMITED
- Current Assignee: LANZATECH NEW ZEALAND LIMITED
- Current Assignee Address: US IL Skokie
- Agent Andrea Schoen
- Main IPC: C12P7/18
- IPC: C12P7/18 ; C12N9/88 ; C12N9/02 ; C12N9/04 ; C12N1/21 ; C12N15/52 ; C12N15/53 ; C12N9/10

Abstract:
The invention provides a recombinant, carboxydotrophic Clostridium bacterium that expresses one or more of pyruvate:ferredoxin oxidoreductase (EC 1.2.7.1), acetolactate synthase (EC 2.2.1.6), and acetolactate decarboxylase (EC 4.1.1.5). The invention further provides a method of producing a fermentation product by fermenting the recombinant bacterium in the presence of a gaseous substrate comprising CO to produce one or more of ethanol, butanol, isopropanol, isobutanol, higher alcohols, butanediol, 2,3-butanediol, succinate, isoprenoids, fatty acids, biopolymers, and mixtures thereof.
Public/Granted literature
- US20160160223A1 RECOMBINANT MICROORGANISMS EXHIBITING INCREASED FLUX THROUGH A FERMENTATION PATHWAY Public/Granted day:2016-06-09
Information query